Đăng xuất
Drug interactions: Associations subject to precautions for use: Take antacids away from other medications administered orally (more than 2 hours if possible).
Calcium polystyrene sulfonate or sodium polystyrene sulfonate: Risk of metabolic alkalosis in people with renal insufficiency.
Citrates: Risk of facilitating the systemic passage of aluminum, particularly in cases of impaired renal function.
Others: Risk of reduced digestive absorption of the following medications taken orally: acetylsalicylic acid, alendronic acid, clodronic acid, etidronic acid, ibandronic acid, oxidronic acid, pamidronic acid, risedronic acid, tiludronic acid, zoledronic acid, alimemazine, atenolol, betamethasone, bictegravir, budesonide, chloroquine, chlorpromazine, chlortetracycline, ciprofloxacin, clindamycin, cortisone, cyamemazine, demeclocycline, dexamethasone, digoxin, dolutegravir, doxycycline, elvitegravir, enoxacin, ethambutol, famotidine, iron, fexofenadine, fluorine, fluphenazine, isoniazid, lansoprazole, ledipasvir, levofloxacin, levomepromazine, levothyroxine, liothyronine sodium, lomefloxacin, lymecycline, methylenecycline, methylprednisolone, metopimazine, metoprolol, minocycline, moxifloxacin, nizatidine, norfloxacin, ofloxacin, oxomemazine, oxytetracycline, pefloxacin, penicillamine, phosphorus, piperazine, pipotiazine, prednisolone, prednisone, proguanil, promethazine, propericiazine, propranolol, tranitidine, rosuvastatin, sulpiride, teriflunomide, tetracycline, thyroxines, vignecycline, tiratricol, triamcinolone, ulipristal.
Association not recommended: Raltegravir or bictegravir: Decreased absorption of these substances.
Drug Incompatibility: Due to the lack of studies on drug incompatibility, do not mix this drug with other drugs.
